✦ LIBER ✦

Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

✍ Scribed by S. Fetscher; J. Finke; R. Engelhardt; R. Mertelsmann; W. Lange

Publisher: Springer
Year: 1997
Tongue: English
Weight: 140 KB
Volume: 74
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early versus late administration of pegf

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

✍ C. Kahl; H. G. Sayer; A. Hinke; M. Freund; J. Casper 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 303 KB

High-dose chemotherapy with autologous h

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer

✍ Y. Tokuda; Masatoshi Ohta; Akira Okumura; Soichi Kuge; Mitsuhiro Kubota; Tomoo T 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 129 KB

High-dose chemotherapy with autologous h

High-dose chemotherapy with autologous hematopoietic stem-cell rescue for patients with malignant brain tumors

✍ Masato Kochi; Yukitaka Ushio 📂 Article 📅 1999 🏛 Springer ⚖ 91 KB

Antimicrobial therapy of febrile complic

Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation

✍ Hartmut Bertz; Holger W. Auner; Florian Weissinger; Hans-Jürgen Salwender; Herma 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 166 KB

High-dose chemotherapy and autologous he

High-dose chemotherapy and autologous hematopoieticstem cell transplantation in patients with second primary malignancies

✍ S. Fetscher; J. Finke; R. Engelhardt; R. Mertelsmann; W. Lange 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 134 KB

Safety and efficacy of high-dose chemoth

Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas

✍ Benjamin Chen; Tauseef Ahmed; Anney Mannancheril; Michael Gruber; Deborah L. Ben 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND Malignant astrocytomas are among the most resistant tumors to curative treatments. Mean survival without treatment is measured in weeks, and even with maximal surgery and radiation, the mean reported survival is < 1 year. The advent of supportive treatments and newer agen